新 口服錠註記 複 藥品代碼 參考價 有效期間 英文名稱 規格量 規格單位 成份名稱 成份含量 成份單位 劑型 藥理分類代碼 製造廠名稱 ATC CODE 未輸入或未生產達五年 -- ---------- -- ---------- --------- --------------- ------------------------------------------------------------------------------------------------------------------------ ------- ----------- ------------------------------------------------------- ------------ ---------- ---------------- ------------ ------------------------------------------ -------- --------------------- * N BC26217100 21.80 1120301 9991231 Betmiga Prolonged-release Tablets 25mg Mirabegron 25.000 MG 持續性藥效錠 120800 ASTELLAS PHARMA TECHNOLOGIES, INC. G04BD12 * N BC26216100 21.80 1120301 9991231 Betmiga Prolonged-release Tablets 50mg Mirabegron 50.000 MG 持續性藥效錠 120800 ASTELLAS PHARMA TECHNOLOGIES, INC. G04BD12 * N KC00911206 21934.00 1120301 9991231 SIMPONI TM (GOLIMUMAB),SOLUTION FOR INJECTION 0.50 ML Golimumab 100.000 MG/ML 注射劑 920000 CILAG AG. L04AB06 * N KC00911209 21934.00 1120301 9991231 SIMPONI TM (GOLIMUMAB),SOLUTION FOR INJECTION 1.00 ML Golimumab 100.000 MG/ML 注射劑 920000 CILAG AG. L04AB06 * N BC25377414 243.00 1120301 9991231 TAFLOTAN OPHTHALMIC SOLUTION 2.50 ML TAFLUPROST 0.015 MG/ML 點眼液劑 524028 SANTEN PHARMACEUTICAL CO., LTD. SHIGA PLAN S01EE05 * Y BC26770405 13.00 1120301 9991231 TAPCOM-S OPHTHALMIC SOLUTION 0.30 ML TIMOLOL MALEATE 5.000 MG/ML 點眼液劑 523699 LABORATOIRE UNITHER S01ED51 * N BC26615405 13.50 1120301 9991231 TAFLOTAN-S OPHTHALMIC SOLUTION 0.30 ML TAFLUPROST 0.015 MG/ML 點眼液劑 524028 SANTEN PHARMACEUTICAL CO. LTD. S01EE05